LRRK2 G2019S promotes the development of colon cancer via modulating intestinal inflammation
Z. Kang, Y. Wang, J. Z. Gao, T. Sakaguchi, T. Maretzky, P. Gurung, S. Short, Y. Xiong
This study shows that LRRK2 G2019S promotes colon cancer by enhancing intestinal inflammation and tumor growth in mice.
bioRxiv · Jun 28, 2023Immunology